In the News

Approved Biosimilars
November 11, 2020
The Association for Accessible Medicines looks forward to working with the incoming Biden-Harris administration to achieve our shared goal of increasing access to safe, effective and affordable generic and biosimilar prescription medicines for all Americans.
IQVIA Biosimilars in the US
October 6, 2020
Today’s IQVIA report confirms that biosimilars are gaining ground to the benefit of patients and the U.S. health care system, but also raises a red flag about the long-term sustainability of the biosimilar market.
August 6, 2020
Developers of generic and biosimilar medicines support diversification of the pharmaceutical supply chain and are working with policymakers to add to our significant manufacturing presence in the United States
increasing access to biosimilars act
July 2, 2020
The Biosimilars Council commends Senators Cornyn and Bennet for the introduction of the Increasing Access to Biosimilars Act.
February 24, 2020
The Council applauds the FDA’s action and continues to call on policymakers to support legislation that would require all patents for the reference biologic to be listed in the Purple Book.
February 5, 2020
CMS’ proposal for a separate preferred specialty tier is a very welcome and significant step that will encourage greater generic and biosimilar adoption for America’s patients.

Recent Tweets

Did you know the Biosimilars Council has a newsletter that includes the latest updates in the #biosimilars industry including policy movement, educational resources and upcoming events?

Subscribe to receive the Biosimilars Bulletin today:

Load More...